| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000024946 |
| Receipt No. | R000028626 |
| Official scientific title of the study | Elucidation of pathophysiology and treatment of aquagenic wrinkling of the palms |
| Date of disclosure of the study information | 2016/11/30 |
| Last modified on | 2018/04/16 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Elucidation of pathophysiology and treatment of aquagenic wrinkling of the palms | |
| Title of the study (Brief title) | Elucidation of pathophysiology and treatment of aquagenic wrinkling of the palms | |
| Region |
|
|
| Condition | ||||
| Condition | Aquagenic wrinkling of the palms, palmoplantar keratoderma, palmoplantar hyperhidrosis, healthy subjects | |||
| Classification by specialty |
|
|||
| Classification by malignancy | Others | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | To elucidate the pathophysiological mechanism that aquagenic wrinkling occurs by comparing the skin between aquagenic wrinkling of the palms, palmoplantar keratoderma, palmoplantar hyperhidrosis and healthy subjects. And also, assessing the safety and efficacy of treatment with non-steroidal anti-inflammatory analgesics by external application. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Evaluate degree of maceration before and after water immersion test on each visit. |
| Key secondary outcomes | Observe the morphology of the palmar skin with an ultrasonic microscope (at the start and the end of the test). Create and compare replica of finger skin print before and after water immersion test (as much as possible on each visit). Self assessment of skin symptoms (per visit). |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Self control |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Loxoprofen sodium hydrate tape, once a day, pasted on the fingers for 3 to 6 months, 1% diclofenac sodium gel and lotion, topical application to the palm for 3 to 6 months twice a day, 20% or 30% aluminum chloride solution, topical application to the palm for 3 to 6 months twice a day | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients who have skin maceration by exposure to water with Aquagenic wrinkling of the palms, palmoplantar keratoderma and palmoplantar hyperhidrosis, and healthy subjects | |||
| Key exclusion criteria | 1) Patients who can not inform disease name.
2) Patients with aspirin asthma and a previous medical history of it. 3) Patients with a history of hypersensitivity to diclofenac sodium, sodium loxoprofen hydrate. 4) Case of pregnancy or expected pregnancy (hope / plan) 5) Cases with age less than 6 at the time of consent acquisition 6) Patients who are judged inappropriate by doctors. |
|||
| Target sample size | 50 | |||
| Research contact person | |
| Name of lead principal investigator | Akiharu Kubo |
| Organization | Keio university school of medicine |
| Division name | Department of dermatology |
| Address | 35 Shinanomachi, Shinjuku-ku, Tokyo |
| TEL | 03-3353-1211(62413) |
| akiharu@keio.jp | |
| Public contact | |
| Name of contact person | Akiharu Kubo |
| Organization | Keio university school of medicine |
| Division name | Department of dermatology |
| Address | 35 Shinanomachi, Shinjuku-ku, Tokyo |
| TEL | 03-3353-1211(62413) |
| Homepage URL | |
| akiharu@keio.jp | |
| Sponsor | |
| Institute | Keio university school of medicine, Department of dermatology |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Keio university school of medicine, Department of dermatology |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Tohoku University Graduate School of Biomedical Engineering |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028626 |